Adiposs

Adiposs is a Swiss clinical-stage biotechnology company specializing in first-in-class medical imaging products for body composition and metabolic health. The company's flagship product, Image-Ab, is a non-invasive CT contrast agent designed to detect and quantify brown adipose tissue, which is a key indicator of metabolic activity and early-stage wasting syndromes. By enabling early detection of conditions like cancer cachexia and sarcopenia before weight loss occurs, Adiposs aims to improve patient outcomes through timely intervention. The company is a spin-off from the University of Geneva and is currently advancing its diagnostic platform across oncology and metabolic disease indications.